Joint (JYNT) Projected to Announce Earnings on Thursday

Key Points

• Joint is expected to report Q3 2026 earnings after the market closes on November 5, with analysts forecasting $0.11 in EPS and $14.85 million in revenue.
• In the prior quarter, Joint earned $0.05 per share, in line with estimates, while revenue of $15.18 million exceeded expectations of $14.57 million.
• Shares opened at $7.26 and have declined from a 52-week high of $10.67. Analyst sentiment has weakened, with the stock carrying a consensus “Reduce” rating.

Joint (NASDAQ:JYNT - Get Free Report) is anticipated to post its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect Joint to post earnings of $0.11 per share and revenue of $14.85 million for the quarter. Individuals are encouraged to explore the company's upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, November 5, 2026 at 5:00 PM ET.

Joint (NASDAQ:JYNT - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.05 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.05. The business had revenue of $15.18 million during the quarter, compared to analyst estimates of $14.57 million. Joint had a net margin of 6.49% and a return on equity of 12.02%. On average, analysts expect Joint to post $0.31 EPS for the current fiscal year and $0.67 EPS for the next fiscal year.

Joint Price Performance

Joint stock opened at $7.26 on Thursday. The stock has a market cap of $102.66 million, a P/E ratio of 26.89 and a beta of 1.09. Joint has a 1 year low of $6.79 and a 1 year high of $10.67. The firm's 50 day moving average price is $7.83 and its 200-day moving average price is $8.62.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Weiss Ratings lowered shares of Joint from a "sell (d+)" rating to a "sell (d)" rating in a research report on Monday. Wall Street Zen downgraded shares of Joint from a "strong-buy" rating to a "buy" rating in a report on Sunday, August 16th. Finally, Zacks Research downgraded shares of Joint from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 7th. Two research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Reduce".

About Joint

The Joint Corp. NASDAQ: JYNT is a healthcare services company that operates The Joint Chiropractic, a network of chiropractic clinics in the United States. The company focuses on providing routine chiropractic care intended to support musculoskeletal health, mobility and general wellness.

The Joint Chiropractic clinics offer services such as chiropractic adjustments and related wellness care. The business model is designed to provide convenient, accessible care through walk-in visits, membership plans and prepaid packages, with an emphasis on transparent pricing and extended operating hours.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.